MICHAEL F KANAN

CIK 1461953 · See Remarks · last filed 2019-03-11

MICHAEL F KANAN is a corporate insider who has filed 26 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for AVDL, was dated Mar 11, 2019. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

26

Lifetime Open-Market Net

-$1.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted See Remarks 50,538 $21.64 $1.09M -$9.8K 5 2019-03-11
AVADEL PHARMACEUTICALS PLC (FLML) Delisted See Remarks 0 $0 4 2017-01-03
SIGMA ALDRICH CORP (SIAL) Delisted VP & Corporate Controller 6,912 -$1.35M 17 2015-11-19

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-03-11 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +18,000 $0 EDGAR
2018-12-18 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Sell (S) −8,429 -$21.0K EDGAR
2018-06-29 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +1,967 $11.2K EDGAR
2017-12-14 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +18,000 $0 EDGAR
2017-01-13 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +18,000 $0 EDGAR
2017-01-03 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Disp (D) −18,000 $0 EDGAR
2017-01-03 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Grant (A) +18,000 $0 EDGAR
2016-12-16 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Grant (A) +18,000 $0 EDGAR
2016-12-16 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Grant (A) +18,000 $0 EDGAR
2015-11-19 SIGMA ALDRICH CORP (SIAL) Delisted Mixed −7,700 -$1.33M EDGAR
Showing 110 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.